Discover
KTTA
Pasithea Therapeutics Corp.
0.57
2 x 0.42
2 x 0.66
bid
ask
+
0.05
9.99%
2 @ 06:00 AM
0.55 -0.01 (2.45%)
| Ytd | -56.05% | |
| 1y | -22.87% |
0.50
day range
0.61
0.28
52 week range
2.06
| Open | 0.50 | Prev Close | 0.52 | Low | 0.50 | High | 0.61 | Mkt Cap | 18.94M |
| Vol | 1.42M | Avg Vol | 862.61K | EPS | -1.42 | P/E | N/A | Forward P/E | -3.75 |
| Beta | 0.82 | Short Ratio | 0.32 | Inst. Own | 2.87% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-16 | 50-d Avg | 0.67 | 200-d Avg | 0.80 | 1yr Est | 2.00 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-11-13 | 2024-09 | 0 | -2.87 | N/A | N/A |
| 2024-08-13 | 2024-06 | 0 | -3.71 | N/A | N/A |
| 2024-05-14 | 2024-03 | 0 | -3.7 | N/A | N/A |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|
Profile
Pasithea Therapeutics Corp., a biotechnology company, engages in discovery, research, and development of treatments for central nervous system disorders, RASopathies, and other diseases. Its lead product candidate PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor for use in the treatment of a range of RASopathies, including neurofibromatosis type 1 oncology indications. The company intends to develop PAS-003, to treat amyotrophic lateral sclerosis; and PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2024-06-12 | NOVAK ALFRED J | Director | 3.50K | Stock Award(Grant) |
| 2023-06-01 | STEINMAN LAWRENCE | Director | 1.33M | Purchase |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | UBS Group AG | 6.57K | 17.47K | 0.52% |
| 2024-09-29 | Morgan Stanley | 1.50K | 3.99K | 0.12% |
| 2024-09-29 | Tower Research Capital LLC (TRC) | 601.00 | 1.60K | 0.05% |
| 2024-09-29 | Royal Bank of Canada | 250.00 | 665.00 | 0.02% |
| 2024-09-29 | JP Morgan Chase & Company | 150.00 | 399.00 | 0.01% |
| 2024-09-29 | Bank of America Corporation | 18.00 | 47.00 | 0.00% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-10-30 | Fidelity Extended Market Index Fund | 2.96K | 7.88K | 0.23% |
| 2024-10-30 | Fidelity Series Total Market Index Fund | 960.00 | 2.55K | 0.08% |
Split
| Split | Date |
|---|---|
| 1 : 20 | 2024-01-02 |